The filing, dated February 17, 2026, reveals this addition to Resolute’s holdings. The overall value of their stake has swelled by $13.03 million, a figure inflated, naturally, by both the new shares and the recent, and possibly ephemeral, appreciation in the company’s price. It’s the sort of arithmetic that comforts fund managers and obscures the fundamental uncertainties of the market.
The analyst, Julien Dumoulin-Smith, revised his judgment of SolarEdge from “underperform”—a euphemism for anticipated stagnation—to “hold,” a state of suspended disapproval. The target price was adjusted upwards, from a meager $30 to $49 per share. Yet, even as this pronouncement was delivered, the stock traded at $51.59—already exceeding the newly established benchmark. A peculiar instance of prophecy overtaken by event, or perhaps a tacit acknowledgment of market irrationality.
Its performance since initial public offering has been, to put it mildly, a study in contradiction. The stock has exhibited a disconcerting tendency to oscillate, a restless energy that defies simple categorization. A surge in 2024 – a figure of 836%, an almost indecent display of growth – was subsequently halved, a correction seemingly designed not to restore equilibrium but to emphasize the inherent instability of the system. And now, in the current reporting period, a decline of 24% – a precise, almost surgical reduction – suggests a process of ongoing calibration, as if some unseen hand is adjusting the parameters of its existence. One wonders if the stock price is merely responding to market forces, or if it is fulfilling some preordained, incomprehensible function.
Just days ago, the oracles at Goldman Sachs deigned to issue a ‘buy’ recommendation, and scarcely a day has passed since Micron (MU 3.72%) delivered earnings that, while spectacular, did little to buoy its own share price. A curious paradox, wouldn’t you agree? It seems investors are as adept at punishing success as they are at ignoring prudence.
The SEC filing dropped February 17th, and it confirmed what my gut’s been telling me for months. They offloaded those shares in Q4 of ’25, leaving them with a measly 126,837 shares – valued at $7.72 million. That’s a $17.47 million net decline, factoring in both the sale and the stock’s… let’s call it ‘performance.’ It’s like watching your favorite pair of shoes slowly disintegrate. You know it’s time to let go, but the memory of their former glory lingers.
There’s a common, and frankly rather frantic, impulse to view these price fluctuations as a signal for immediate, possibly panicked, investment. The logic, as near as anyone can determine, is that if something is getting more expensive, buying shares in the thing that makes the expensive thing is a sound strategy. It’s not entirely illogical, of course, but it’s a bit like deciding to invest in umbrellas during a hurricane. A better approach, and one that requires a slightly longer attention span than most goldfish, is to consider a stock you can comfortably hold for, say, the next decade or so. Chevron (CVX +1.53%) fits that description, mostly because it’s still there.
In the previous cycle, advertising revenue—a tributary feeding the larger stream—accounted for approximately 3% of the total. A figure, one notes, that feels both substantial and utterly insignificant. Projections for 2026 suggest a rise to nearly 6%. A doubling, almost. Yet, one wonders if this growth is organic, or merely an illusion created by the shifting sands of the digital landscape. Should this revenue climb as anticipated, it would be interpreted as bullish—a temporary reprieve from the inevitable. Outperformance here suggests a capacity for revenue extraction beyond the increasingly strained model of subscription increases—a precarious balancing act. However, any deviation from the forecast—any hint of weakness—could initiate a cascade of re-evaluations.
The multi-million dollar expansion is anchored by the opening of a new office in New York City and the appointment of financial industry veteran John Andrews as Chief Financial Officer. Because nothing says “trust me, I know what I’m doing” like a guy who’s been in finance for 25 years. Wait, that’s not a joke-actually, maybe it is.
Broadcom, a company that makes the little bits and pieces that make the big machines work, is poised to do very well from this. They make the chips, the ASICs, the things that actually do the thinking. Sixty percent of the market, they say. That’s a lot of thinking. They predict a hundred billion in AI chip revenue by 2027. Just two years from now. The company did sixty-four billion last year, total. So, five times as much. It’s like watching a dandelion grow into a small forest. So it goes.
Everyone’s chasing yield, you see. A desperate scramble for income in a world where interest rates are a historical joke. These dividend hounds, they’re sniffing out the highest payouts, ignoring the crimson flags waving furiously in the breeze. It’s like watching lemmings line up for the cliff. They want cash now. They’ll take any dividend, no matter how unsustainable, how… fragile. It’s a fool’s game. A temporary fix for a terminal illness.